Clinical Trial Update: Study of ONO-2506 in Patients With Acute Ischemic Stroke [Phase 2, Phase 3]

View source ↗

Summary

Completed Phase 2/3 clinical trial assessing ONO-2506 in patients with acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• ONO-2506

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Stroke | Phase 2, Phase 3 | Status: COMPLETED